Literature DB >> 12740666

Two cases of cerebral aspergillosis successfully treated with voriconazole.

V de Lastours1, A Lefort, M Zappa, V Dufour, N Belmatoug, B Fantin.   

Abstract

Described here are two cases of cerebral aspergillosis successfully treated with voriconazole after the failure of first-line treatment with amphotericin B deoxycholate. In both cases, clinical and radiological cure was achieved within 6 weeks. Voriconazole should be considered as first-line therapy for cerebral aspergillosis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12740666     DOI： 10.1007/s10096-003-0934-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  17 in total

1.  Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.

Authors:  S Schwartz; D Milatovic; E Thiel
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

Review 2.  Invasive aspergillosis.

Authors:  D W Denning
Journal:  Clin Infect Dis       Date:  1998-04       Impact factor: 9.079

3.  Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Authors:  D A Stevens; V L Kan; M A Judson; V A Morrison; S Dummer; D W Denning; J E Bennett; T J Walsh; T F Patterson; G A Pankey
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  Effect of alcohol consumption on host release of interleukin-17 during pulmonary infection with Klebsiella pneumoniae.

Authors:  J E Shellito; M quan Zheng; P Ye; S Ruan; M K Shean; J Kolls
Journal:  Alcohol Clin Exp Res       Date:  2001-06       Impact factor: 3.455

Review 5.  Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery--case report and review of the literature.

Authors:  J M Coleman; G G Hogg; J V Rosenfeld; K D Waters
Journal:  Neurosurgery       Date:  1995-04       Impact factor: 4.654

6.  Invasive aspergillosis in a "healthy" patient.

Authors:  K J Ascah; R H Hyland; M A Hutcheon; S J Urbanski; W Pruzanski; E L St Louis; D P Jones; E C Keystone
Journal:  Can Med Assoc J       Date:  1984-08-15       Impact factor: 8.262

7.  Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

Authors:  O Lortholary; M C Meyohas; B Dupont; J Cadranel; D Salmon-Ceron; D Peyramond; D Simonin
Journal:  Am J Med       Date:  1993-08       Impact factor: 4.965

8.  CNS aspergillosis in organ transplantation: a clinicopathological study.

Authors:  J Torre-Cisneros; O L Lopez; S Kusne; A J Martinez; T E Starzl; R L Simmons; M Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis.

Authors:  D W Denning; J Y Lee; J S Hostetler; P Pappas; C A Kauffman; D H Dewsnup; J N Galgiani; J R Graybill; A M Sugar; A Catanzaro
Journal:  Am J Med       Date:  1994-08       Impact factor: 4.965

10.  Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.

Authors:  T J Walsh; D B Hier; L R Caplan
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422
View more
  8 in total

1.  The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis.

Authors:  S Schwartz; A Reisman; P F Troke
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.

Authors:  Stephan Ehrmann; Frédéric Bastides; Valérie Gissot; Emmanuelle Mercier; Pascal Magro; Eric Bailly; Annick Legras
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

Review 4.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 5.  CNS aspergillosis: recognition, diagnosis and management.

Authors:  Markus Ruhnke; Grzegorz Kofla; Kirsten Otto; Stefan Schwartz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 6.  Intracranial aspergillosis in immunocompetent adult patients without risk factors: a systematic review.

Authors:  Kyoung Su Sung; Jaejoon Lim; Hun Ho Park
Journal:  Neurosurg Rev       Date:  2022-03-12       Impact factor: 3.042

7.  Central nervous system infections in transplantation.

Authors:  Todd Czartoski
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

8.  Voriconazole in the management of nosocomial invasive fungal infections.

Authors:  Javier Pemán; Miguel Salavert; Emilia Cantón; Isidro Jarque; Eva Romá; Rafael Zaragoza; Angel Viudes; Miguel Gobernado
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.